Pathology & Laboratory Medicine

Publications

Filter By Faculty

Filter by Principal Investigator

2000

Zhou P, Bogacki R, McReynolds L, Howley PM. Harnessing the ubiquitination machinery to target the degradation of specific cellular proteins. Mol Cell. 2000;6(3):751-6.

Loda M, Xu X, Pession A, Vortmeyer A, Giangaspero F. Membranous expression of glucose transporter-1 protein (GLUT-1) in embryonal neoplasms of the central nervous system. Neuropathol Appl Neurobiol. 2000;26(1):91-7.

Martinez J, Sanchez T, Moreno JJ. Regulation of prostaglandin E2 production by the superoxide radical and nitric oxide in mouse peritoneal macrophages. Free Radic Res. 2000;32(4):303-11.

Gulbahce HE, Manivel JC, Jessurun J. Pulmonary cytolytic thrombi: a previously unrecognized complication of bone marrow transplantation. Am J Surg Pathol. 2000;24(8):1147-52.

Signoretti S, Montironi R, Manola J, Altimari A, Tam C, Bubley G, et al. Her-2-neu expression and progression toward androgen independence in human prostate cancer. J Natl Cancer Inst. 2000;92(23):1918-25.

Fiorentino M, Altimari A, D'Errico A, Cukor B, Barozzi C, Loda M, et al. Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma. Clin Cancer Res. 2000;6(10):3966-72.

Demichelis F, Berloffa F, Eccher C, Larcher B, Galvagni M, Sboner A, et al. Design and initial implementation of a regional tele-oncology project. J Telemed Telecare. 2000;6 Suppl 1:S71-3.

Chiarle R, Budel LM, Skolnik J, Frizzera G, Chilosi M, Corato A, et al. Increased proteasome degradation of cyclin-dependent kinase inhibitor p27 is associated with a decreased overall survival in mantle cell lymphoma. Blood. 2000;95(2):619-26.

Tao J, Savargaonkar P, Vallejo C, Cesarman E, Fuchs A. Aggressive natural killer cell lymphoma presenting as an anterior mediastinal mass in a patient with acquired immunodeficiency syndrome. Arch Pathol Lab Med. 2000;124(2):304-9.

Papasavvas E, Ortiz GM, Gross R, Sun J, Moore EC, Heymann JJ, et al. Enhancement of human immunodeficiency virus type 1-specific CD4 and CD8 T cell responses in chronically infected persons after temporary treatment interruption. J Infect Dis. 2000;182(3):766-75.